Madrigal Pharmaceuticals, Inc. (MDGL) operating KPIs
MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026Score 5/3085% above fair value
$430.36−1.34 (-0.31%)
Close on Oct 30, 2026Market cap $9.94BP/E –Yield –
KPIs
Operating metrics that drive Madrigal Pharmaceuticals's business
Coming soon
This tab will track the numbers specific to Madrigal Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.